Focal One ® is a registered trademark of EDAP TMS. The Focal One® HIFU Robotic System uses high intensity focused ultrasound (HIFU) technology that allows for precise targeting within the prostate, while sparing healthy surrounding tissue and minimizing side effects for prostate cancer treatment patients.

LYON, France, January 5, 2023 -- EDAP TMS SA (NASDAQ: EDAP) (the “Company”), the global leader in robotic energy-based therapies, announced today that the Company experienced robust demand for its Focal One HIFU technology in the fourth quarter of 2022, placing nine Focal One machines in the U.S.

With the addition of the ExactVu™ Micro-Ultrasound device, EDAP TMS is now the only company offering a complete solution from diagnostics to focal treatment of Prostate Cancer. EDAP TMS also produces and distributes other medical equipment including the Sonolith ® i-move lithotripter and lasers for the treatment of urinary tract stones using ...

Learn product details about how Focal One combines the latest imaging and High Intensity Focused Ultrasound (HIFU) technology to precisely contour and ablate the targeted lesion while avoiding critical structures. This innovative treatment modality provides precision and optimal patient outcomes.

2024年10月1日 · With the addition of the ExactVu™ Micro-Ultrasound device, EDAP TMS is now the only company offering a complete solution from diagnostics to focal treatment of Prostate Cancer.

Edap TMS SA是一家控股公司，分为两个部门，即HIFU和UDS。 HIFU部门使用HIFU技术开发、制造和销售用于侵入性破坏某些类型肿瘤的装置。它销售两种HIFU设备：（1）Ablatherm，治疗器官局限性前列腺癌；（2）Focal One，用于局部前列腺癌的局部治疗，仅摧毁靶向癌细胞。

EDAP TMS : Historique et innovations dans le traitement du cancer de la prostate et des calculs des voies urinaires. Depuis plus de 40 ans, EDAP TMS a pour vocation de développer des innovations majeures pour une approche non-invasive des troubles urologiques.

2024年12月5日 · By combining the latest technologies in imaging, robotics and precise non-invasive energy delivery, EDAP TMS introduced the Focal One ® in Europe and in the U.S. as the leading prostate focal therapy controlled by urologists with the potential to expand to multiple indications beyond prostate cancer.

2025年2月6日 · Cortechs.ai and EDAP TMS (EDAP) announced the successful completion of the world’s first OnQ Prostate-assisted Focal One Robotic HIFU procedure at the University of California, San Francisco...

By combining the latest imaging and treatment technologies, Focal One brings the answer to current requirements for ideal focal therapy: accurate and MR-fused imaging, non-invasive approach, precise and efficient therapeutic HIFU energy and end-of-treatment validation imaging with Contrast-Enhanced Ultrasound.